Corporate News of MPH Health Care AG: Q1 Results
First Quarter 2019: Preliminary IFRS-result, equity (Net Asset Value) of 263.49 million EUR and therefore 6.15 EUR per share.
Berlin, 23rd May, 2019: MPH Health Care AG (ISIN: DE000A0L1H32) announces preliminary IFRS results for the first quarter of 2019. Accordingly, the preliminary IFRS period loss amounted to -5.64 million EUR (previous year: period profit of 26.75 million EUR). The reason for the net loss for the period lies in the fair value measurement of the share prices of the investments on 31 March 2019 compared to the share prices on 31 December 2018.
Equity amounted to 263.49 million EUR as of 31 March 2019 (previous year: 267.42 million EUR). Net asset value (NAV) fell slightly year-over-year from 6.25 EUR (31 March 18) to 6.15 EUR (31 March 19) per share.
“We are confident about the further development of our listed investments HAEMATO AG, M1 Kliniken AG and CR Capital Real Estate AG in 2019, despite the brief decline in the share price. The healthcare market in Germany has been growing faster than the economy as a whole for many years now, and we are systematically benefiting from this with our investments, e.g. with HAEMATO for pharmaceuticals in the insurance-financed market and with M1 Kliniken in the private payer market,” says Patrick Brenske, CEO of MPH.
Due to the sustained positive results of recent years, the Executive Board will propose an unchanged dividend of 20 cents per share at the Annual General Meeting on 17 July 2019.
The Annual Report 2018 of MPH Health Care AG was published on the website on May 22, 2019 and is available for download at https://www.mph-ag.de/en/en/reports/. Net asset value increased by 12% from 5.62 EUR (31 Dec. 17) to 6.29 EUR (31 Dec. 18) per share in the fiscal year 2018.